Switching From Prasugrel to Clopidogrel Navigating in Unknown Waters

被引:8
|
作者
Angiolillo, Dominick J. [1 ]
Rollini, Fabiana [1 ]
机构
[1] Univ Florida, Coll Med Jacksonville, Jacksonville, FL 32209 USA
关键词
P2Y(12) receptor antagonist; platelet reactivity; switch; ACUTE CORONARY SYNDROMES; ANTIPLATELET THERAPY; DIRECTIONS;
D O I
10.1016/j.jcin.2012.12.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:166 / 168
页数:3
相关论文
共 50 条
  • [31] Impact of Diabetes Mellitus on the Pharmacodynamic Effects of Prasugrel and Ticagrelor After Switching From Clopidogrel in Patients With Coronary Artery Disease
    Rollini, Fabiana
    Rivas, Jose
    Nagaraju, Deepa
    Moon, Jae Youn
    Rivas, Andrea
    Agarwal, Malhar
    Kureti, Megha
    Been, Latonya
    Suryadevara, Siva
    Zenni, Martin M.
    Bass, Theodore A.
    Angiolillo, Dominick J.
    Franchi, Francesco
    CIRCULATION, 2017, 136
  • [32] Switching from clopidogrel to prasugrel to protect early invasive treatment in acute coronary syndromes: Results of the switch over trial
    Ottani, Filippo
    Femia, Eti Alessandra
    Cattaneo, Marco
    Caravita, Luciano
    Attanasio, Chiara
    Galvani, Marcello
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 255 : 8 - 14
  • [33] VERifynow in DIabetes high-on-treatment platelet reactivity: a pharmacodynamic study on switching from clopidogrel to prasugrel (VERDI study)
    Cubero Gomez, J. M.
    Acosta Martinez, J.
    Mendias Benitez, C.
    Diaz De La Llera, L.
    Fernandez Quero, M.
    Guisado Rasco, A.
    Gil Ortega, M. Villa
    Sanchez Gonzalez, A.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1165 - 1165
  • [34] Prasugrel or Clopidogrel in patients with coronary intervention
    Schroer, K.
    INTERNIST, 2009, 50 (11): : 1293 - 1296
  • [35] Switching from clopidogrel hydrogen sulfate to clopidogrel besylate
    Meves, S. H.
    Overbeck, U.
    Kaiser, A.
    Krogias, C.
    Neubauer, H.
    NERVENARZT, 2010, 81 (08): : 992 - 997
  • [36] Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Japanese Patients With Stable Coronary Artery Disease
    Nishi, Takeshi
    Ariyoshi, Noritaka
    Nakayama, Takashi
    Fujimoto, Yoshihide
    Sugimoto, Kazumasa
    Takahara, Masayuki
    Wakabayashi, Shinichi
    Koshizaka, Masaya
    Hanaoka, Hideki
    Kobayashi, Yoshio
    CIRCULATION JOURNAL, 2015, 79 (11) : 2439 - 2444
  • [37] Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience
    De Luca, Giuseppe
    Verdoia, Monica
    Schaffer, Alon
    Suryapranata, Harry
    Parodi, Guido
    Antoniucci, David
    Marino, Paolo
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (03) : 388 - 394
  • [38] Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease
    Mattia Galli
    Fabiana Rollini
    Latonya Been
    Martin M. Zenni
    Dominick J. Angiolillo
    Francesco Franchi
    Journal of Thrombosis and Thrombolysis, 2022, 54 : 461 - 469
  • [39] Switching from high-dose clopidogrel to prasugrel in ACS patients undergoing PCI: a single-center experience
    Giuseppe De Luca
    Monica Verdoia
    Alon Schaffer
    Harry Suryapranata
    Guido Parodi
    David Antoniucci
    Paolo Marino
    Journal of Thrombosis and Thrombolysis, 2014, 38 : 388 - 394
  • [40] Switching from clopidogrel to prasugrel resolves vascular inflammation in patients receiving long-term aspirin plus clopidogrel therapy after coronary stent implantation
    Bekki, Munehisa
    Tahara, Nobuhiro
    Tahara, Atsuko
    Maeda-Ogata, Shoko
    Sugiyama, Yoichi
    Honda, Akihiro
    Igata, Sachiyo
    Harada, Atsushi
    Hirakawa, Yuji
    Kurata, Seiji
    Fujimoto, Kiminori
    Abe, Toshi
    Fukumoto, Yoshihiro
    Ueno, Takafumi
    JOURNAL OF NUCLEAR CARDIOLOGY, 2021, 28 (03) : 1191 - 1192